You have no items in your shopping cart.
TSLP Antibody
Description
Images & Validation
−| Tested Applications | ELISA, FA, FACS, In vivo |
|---|---|
| Reactivity | Human, Monkey |
Key Properties
−| Clonality | Monoclonal |
|---|---|
| Target | TSLP |
| Source/Expression System | CHO |
| Molecular Weight | 144.6 kDa |
| Purity | >95% |
| Purification | Protein A |
| Endotoxin | <0.001 EU/ug |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Concentration | Batch dependent |
| Disclaimer | For research use only |
Similar Products
−TSLP Antibody [orb1240256]
ELISA, IF, IHC-P, WB
Human, Mouse
Rabbit
Polyclonal
Unconjugated
0.1 mg, 0.02 mgTSLP Rabbit Polyclonal Antibody [orb11532]
IF, IHC-Fr, IHC-P, WB
Human
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μlRat Thymic Stromal Lymphopoietin (TSLP) ELISA Kit [orb780313]
Rat
15.63-1000 pg/mL
5.6 pg/mL
48 T, 96 TMouse Thymic Stromal Lymphopoietin (TSLP) ELISA Kit [orb777789]
Mouse
15.63-1000 pg/mL
5.4 pg/mL
96 T, 48 T

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-TSLP Reference Antibody (tezepelumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-TSLP Reference Antibody (tezepelumab)is more than 98.64% ;determined by SEC-HPLC.

Immobilized human TSLP His at 2 μg/mL can bind Anti-TSLP Reference Antibody (tezepelumab);EC50=0.0518μg/mL.


Anti-TSLP Reference Antibody (tezepelumab)-induced FACS Blocking activity was evaluated using TSLPR/IL7R-CHO-K. The IC50 was approximately 0.0802 μg/mL.

Tezepelumab reduced levels of IL13 in BALF of OVA asthma model on B-hTSLP/hTSLPR mice. The result showed significant IL13 inhibition effects at 15 mpk.
Quick Database Links
UniProt Details
−Documents Download
Request a Document
Protocol Information
TSLP Antibody (orb1805495)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review





















